Get Permission Pancholi, Sharma, Bhopalwala, and Khan: Pharmacognosy of Indian medicinal plants and their future aspects as an Anti-HIV agent: A review


Introduction

Worldwide around ~38.4 million people (both men and women equally affected) suffering from HIV infection with 1.5 million new cases and approx~0.65 million deaths.1 Present condition in Indian scenario, 2.4 million people are seropositive, among them 1.05 million are female and 0.69 million were children.2 Along with HIV infection reproductive tract infections (RTIs) and sexually transmitted infections (STIs) were also associated with large human suffering. According to data given by WHO 374 million new cases of syphilis, gonorrhoea, chlamydia, trichomoniasis and other HIV related STD’s infect adults aged 15-49 years.3 The use of ‘condoms’ has been proposed to prevent HIV and other STD transmissions along with resolving conception purpose. Reduction of sexual pleasure reduces its usage, however female condom has been developed to overcome this problem. High cost and objections from male partners also risks female life.4 Anti-retroviral drug therapy has been used by several governmental programmes to combat transmission of HIV, reduce viral load and the chances of mother-to-child HIV infection. Several reports have been documented on the issue of drug resistance along with patient sufferings in the form of diarrhea, nausea, lipodistrophy, hyperglycemia, liver toxicity, pancreatitis and neuropathy.5 To resolve these problems, the use of microbicides has recently been proposed.6

Microbicides may be available either in the form of a cream, gel, lubricant or even in the form of a tablet and can be applied topically to the vaginal or rectal surface. These microbicide should be applicable hours before sex, not lead to the lesion and aberration in epithelial layer, preserve natural vaginal environment and not show any allergic reactions.7

For the purpose of this study, ten Indian traditional medicinal plants, Albizia procera (Roxb.) Benth (fam. fabaceae), Tridax procumbens L. (fam. Asteraceae), Achyranthes aspera L. (fam. Amaranthaceae), Ficus benghalensis L. (fam. Moraceae), Mallotus philippinensis (Lam.) Muell. Arg. (Fam. Euphorbiaceae), Rosa centifolia L. (fam. Rosaceae), Strychnos potatorum L.f. (fam. Loganiaceae), Annona reticulate L. (fam. Annonaceae), Ficus infectoria Miq. (Fam. Moraceae) and Annona squamosa L. (fam. Annonaceae) were selected to investigate there in vitro inhibitory activity against entry inhibition/replication of HIV-1 as well as directly inactivating HIV or preventing HIV from attaching, entering or replicating in susceptible target cells.

Medicinal Plants

Strychnos potatorum

Strychnos potatorum L.f. (fam. Loganiaceae) used in gonorrhoea, leukorrhea8 with suppressive effects on sperm motility.9 A. squamosa fruit pulp with spermicidal properties significantly inhibit HIV replication in H9 lymphocytes.10 This make it additional desirable attribute for a vaginal microbicide.11 Methanolic extract of S. potatorum showed activity with preliminary IC80 in the range of 29.17–79.35 μg/ml giving estimated TI of 24 in cell free HIV-1Ada5 strain.12

Figure 1

Strychnos potatorum

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2e2ada00-c775-4e00-b439-8b97ba5a701dimage1.jpeg

Rosa centifolia

Rosa centifolia L., a flowering plant of Rosaceae family, commonly known as Cabbage rose were also known for their antiviral activities. In chemistry, were Phenyl ethanol (43%), Geraniol (10.5%), Geranyl acetate (15.6%), Benzaldehyde (1.5%), Nerol (5-10%), Citronellyl acetate (0.3%), Linalool (6.9%), Benzyl alcohol (3.3%) have been isolated. Along with oils it also contains tannins, mineral salts, salt of mallic acid and tartaric acid.13 Methanolic extract of the leaves of R. centifolia showed very low anti-HIV activities.12

Figure 2

Rosa centifolia

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2e2ada00-c775-4e00-b439-8b97ba5a701dimage2.jpeg

Albizia procera

Albizia procera (Roxb.) Benth, a member of Fabaceae family is found all over Indian territories. Traditionally bark decoction used for the treatment of rheumatism, hemorrhage, and stomach-ache.14 Laboratory analysis of bark ethanolic, ethyl acetate, aqueous, hexane-chloroform extracts inhibits the integrase enzyme with lower IC50 (19.5, 19.1, 21.3, and >100 μg/ml respectively). Major chemical constituents isolated from plant are catechin and protocatechuic acid. Catechin showed substantial activity against intergase enzyme with IC50 value of 46.3 µM, on the other hand protocatechuic acid showed lower protection.15

Figure 3

Albizia procera

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2e2ada00-c775-4e00-b439-8b97ba5a701dimage3.jpeg

Achyranthes aspera

Achyranthes aspera L. (fam. Amaranthaceae), is a well-known folk medicine in Indian subcontinent. Oleanolic acid reported in the plant which demonstrated potential effects against herpes simplex virus type-I, with EC50 6.8 μg/ml and type-II, HSV-2 with EC50 7.8 μg/ml.16 Oleanolic acid and crude ethanolic extract inhibit early stage of virus multiplication (2–6 h of post infection). methanolic extract of A. aspera which showed activity with preliminary IC80 in the range of 18–35 μg/ml giving TI of 14, 35 and 13 in cell free HIV-1IIIB, HIV-1Ada5 and cell associated HIV-1IIIB respectively.12 

Figure 4

Leaves of Achyranthes aspera

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2e2ada00-c775-4e00-b439-8b97ba5a701dimage4.jpeg

Annona squamosa

Annona squamosa L. (Annonaceae), known as the custard apple tree present throughout India. Annona squamosa used as insecticidal, anti-tumor, anti-diabetic, antioxidant, anti-lipidimic and anti-inflammatory agent.17 A leaf decoction was taken in the case of dysentery. They possess a wide variety of compounds like acetogenins which were responsible for anti-feedant, anti-malarial, cytotoxic and the immunosuppressive activities.18 Two diterpenes annosquamosins A and B demonstrated the anti-HIV activity and the anti-platelet aggregation activity.19

Figure 5

Leaves of Annona squamosa

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2e2ada00-c775-4e00-b439-8b97ba5a701dimage5.png

Tridex procumbens

T. Procumbens is a well-known Ayurvedic herb of Indian sub-continent with the history of traditional uses.  Plant is widely to treat wounds, skin diseases and to stop blood clotting. It possesses anticoagulant, antileishmanial, antioxidants, anticancer, immunomodulatory agent, insecticidal, anthelmintic cardiovascular, antiseptic, antimicrobial, and insecticidal properties.20 Methanolic extract of T. procumbens does not exhibit anti-HIV activity.21

Figure 6

Tridex procumbens

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2e2ada00-c775-4e00-b439-8b97ba5a701dimage6.jpeg

Annona reticulata

The plant is traditionally used for the treatment of epilepsy, dysentery, cardiac problems, worm infestation, constipation, haemorrhage, antibacterial infection, dysuria, fever, ulcer etc. It also has antifertility, antitumour and abortifacient properties.21 The leaves of A. reticulata tetrahydroisoquinoline alkaloid with cardiotonic activity and a bioactive acetogenin from its bark have been isolated. Leaves shows potent antidiabetic activity. Some workers isolated flavonoids from leaves. Ethanol extract of the leaves and stem is reported to have anti-cancer.22 Extracts from the peels of A. reticulata showed high antiviral activity, with HIV-1 reverse transcriptase inhibition values of 78.63 ± 0.97%.23

Figure 7

Annona reticulata

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2e2ada00-c775-4e00-b439-8b97ba5a701dimage7.jpeg

Ficus infectoria

The plant demonstrated a wide spectrum of in vitro and in vivo pharmacological activities like, antidiabetic, cognitive enhancer, wound healing, anticonvulsant, anti-inflammatory, analgesic, antimicrobial, antiviral, hypolipidemic, antioxidant, immunomodulatory, antiasthmatic, parasympathetic modulatory, esterogenic, antitumor, antiulcer, antianxiety, antihelmintic, endotheilin receptor antagonistic, apoptosis inducer and hypotensive.24

F. infectoria exhibited activity in both laboratory adapted strains with estimated IC80 in the range of 18–73 μg/ml giving therapeutic index between 12–32.12

Figure 8

Ficus infectoria

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2e2ada00-c775-4e00-b439-8b97ba5a701dimage8.jpeg

Mallotus philippinensis

Mallotus (family: Euphorbiaceae) is a large genus of trees and shrubs distributed in subtropical regions of the Old World with about 20 species in India. It is a tree species with the height of 1500 m. Mature fruits hairs The collected material is fine, granular powder, dull red, or madder red-colored and floats on water. This plant is traditionally used for antifilarial, antibacterial, anti-inflammatory, and immune-regulatory activity.23 Plant extract does not showed any anti-HIV activity in aqueous as well as in methanolic extract.12

Figure 9

Mallotus philippinensis

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2e2ada00-c775-4e00-b439-8b97ba5a701dimage9.jpeg

Ficus benghalensis

Ficus is a large tree, 20–30 m high, with wide-spreading branches bearing aerial roots. The root extract used to boost the immunity. Plant is extensively used in folklore medicines for its vermicidal, astringent, hypotensive, and antidysenteric propertis.25 The active components isolated from F. benghalensis were glucosides flavonoids26, 27 etc. 

Aqueous extract of F. benghalensis exhibited activity in both laboratory adapted strains with estimated IC80 in the range of 18–35 μg/ml giving TI between 12–32.12

Figure 10

Ficus benghalensis

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2e2ada00-c775-4e00-b439-8b97ba5a701dimage10.jpeg

Methanolic extracts of Tridax procumbens, Mallotus philippinensis, Annona reticulate, aqueous extract of Ficus benghalensis and hydroalcoholic extract of Albizzia lebbeck did not exhibit anti-HIV activity in all the tested strains.12

Microbicides

A combination of anti-retroviral drugs has been used successfully to treat HIV infected humans and their introduction has prolonged their life span. Anti-retroviral drug therapy has been found to be useful to combat blood-to-blood transmission of HIV due to use of contaminated needles in drug addicted cases or transfusion of infected blood. These drugs also reduce the viral load and hence minimize the chances of mother-to-child HIV transmission. Long-term usage of available anti-retroviral drugs leads to the issue of drug resistance, and severe side effects such as diarrhea, nausea, lipodistrophy, hyperglycemia, liver toxicity, pancreatitis & neuropathy.

Microbicides are prophylactic agents, applied to the vagina or rectum to protect against sexually transmitted infections (STIs) including HIV. They can be in the form of gels, creams, films, or suppositories.

An ideal microbicide should be applicable hours before sex, preserve the natural anatomy of female reproductive tract (does not lead to lesion and aberration in epithelial layer), protect the natural vaginal micro-ecological system and should not generate any pro-inflammatory cytokines. Microbicides may act by

  1. Virucidal activity

  2. Inhibiting HIV entry/fusion by preventing (i) attachment of the viral gp120 to the CD4 T cell receptor, (ii) binding of the gp120 to CCR5 or CXCR4 co-receptors, and (iii) fusion of the viral and cellular membranes.

  3. Inhibiting HIV reverse transcriptase (RT) activity

  4. Inhibit HIV protease activity

  5. Inhibit HIV integrase activity

  6. Unique mechanism of action like inhibiting the gene expression in HIV (e.g. Tat inhibitors), compounds with immunomodulatory properties, etc.

An ideal microbicide should possess the following qualities:

Should be safe: It should preserve the natural anatomy of female reproductive tract; absence of pro-inflammatory response; protect natural vaginal micro-ecological system including lactobacilli

Should be acceptable: Applicable hours before sex; not messy or ‘leaky’; rapid and even spreading property; long acting; not smelly and ‘taste’ OK

Should be effective against HIV and a wide range of pathogens causing STIs e.g. Trichomonas vaginalis, Neisseria gonorrhoeae, Treponema pallidum, Chlamydia trichomatis and Herpes Simplex virus

Should be cost effective and affordable: The Phase-III clinical trials of microbicides in humans based on cellulose sulfate (Ushercell),28 Carrageenan (Caraguard)29, 30 and Buffer Gel (PRO2000)31 have not yielded the promising results to prevent HIV infection. However, recent results on Phase-III clinical trials of microbicide based on tenofovir showed that HIV incidence was 54% lower in high adherers (gel adherence >80%), in the tenofovir gel arm as compared to placebo control.32, 33 However, this study (VOICE) of oral Tenofovir pre-exposure prophylaxis has been terminated because oral oral intake of tenofovir has not shown any benefit as compared to placebo pills (wwww.aidsmap.com/Tenofovir-PrEP-arm-dropped-in womems-HIV-prevention-trial). However, the trial will continue to test Tenofovir microbicide gel and Truvada (an oral tablet with Tenofovir plus emtricitabine). The findings of VOICE clinical trials warrant an urgent need of active participation of various investigators engaged in the development of microbicides and arrives at more stringent preclinical evaluation criteria. A better understanding of the mechanisms involved in HIV transmission had helped us in designing appropriate and more effective strategies for vaccine and microbicide development. Sexually transmitted infections, leading to genital ulcers, have been strongly associated with an increased risk for HIV infection. STIs also increase viral shedding in the genital tract of HIV-infected individuals. It may be due to STIs-related ulcers, which can serve as portals for viral entry across the mucosal layer of vagina. Non-ulcerative infections increase susceptibility to HIV infection by triggering the pro-inflammatory responses that enhance viral replication or by increasing the number of activated CD4+ T cells and DCs trafficking from the genital mucosa to the lymph nodes. HIV infects several cell types such as CD4+ T cells, DCs and macrophages that are present in the vaginal mucosa. In addition to CD4, HIV uses a variety of co-receptors to enter the cells, including CXCR4 and CCR5. Recently, it has been shown that compounds, may block co-receptors, provide incomplete protection from infection via migratory DCs might still proceed.34

Thus, there is an urgent need for novel prophylactic methods, called microbicides. These topical products, had to be applied to the genital area, with the capacity to prevent transmission of STDs, particularly the HIV and with or without sperm-inhibitory activity, thereby serving as both contraceptives and non-contraceptive modes.35 Topical microbicides can provide excellent potential for a female-controlled, preventive option, which would not require negotiation, consent or even knowledge of the partner. Both women and men would benefited.36 Substantial amount of research has been done and a lot more is in progress to isolate the active leads from plants for prevention of transmission of HIV and treatment of AIDS. These natural compounds and their synthetic derivatives may act by different mechanisms, targeting critical steps within the replication cycle of HIV. Given the successful history of natural product based drug discovery, a library of close to one thousand plant and fungal extracts was screened for antiretroviral activity by Adeleke and Babalola.37 A review38 on natural products under development for anti-HIV activity has been published by National Cancer Institute (USA). An Indian group on the anti-HIV activity of the medicinal plants has also published an extensive review. Several natural products acting as anti-HIV surface-active agents, reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, integrase inhibitors and protease inhibitors have been reported. Vlietinck39 have summarized many compounds of plant origin that inhibit HIV during various stages of life cycle. These include several alkaloids, carbohydrates, coumarins, flavonoids, lignans, phenolics, proteins, quinines/xanthones, phospholipids, tannins, and terpenes from various plants. Given the successful history of natural product based drug discovery, a library of close to one thousand plant and fungal extracts was screened for antiretroviral activity several studies have been conducted to screen the plants used in folk medicine for anti-HIV activity. These include plants from Panama,40 Indonesia,41 Egyptian folk medicine, 42 Ayurvedic medicine43 and traditional Chinese herbs.44

For compounds that act directly against the virus—for example, before integration of the virus into genetic material—it will be vital to check that drug resistance does not emerge, and for those that block cell surface receptors it will be necessary to ensure that they are not circumvented by the virus interacting with other receptors. Defensins and maganins are examples of this class. Other compounds with encouraging antimicrobial profiles include cellulose acetate phthalate (CAP) and CTC-96, an organocobalt compound. CAP has shown virucidal activity against HIV-1, HSV-1 and HSV-245 CAP blocks infection by both cell free and cell associated HIV as well as blocks CXCR4 and CCR5-tropic virus types in tissue explant.46 Preclinical evaluation to till date these microbicides does not increase in the production of proinflammatory mediators during or after exposure and not modify the epithelial resistance to leukocyte.47 The micronised form of CAP (~1µm diameter) leads to disintegration and loss of infectivity of HIV-1 and its lack of systemic absorption increases its bioavailability to the topical surface. Due to heavy vaginal discharges in CAP based microbicide, the clinical trials were aborted.48 The combination of CAP and UC781 (a tight-binding HIV-1 reverse transcriptase inhibitor) has resulted in significant synergistic and complementary effects against HIV-1 infection and its evaluation is under progress.49

Several research institutions including Talwar Research Foundation, New Delhi; National AIDS Research Institute (NARI), Pune; National Center for Cell Science, Pune; National Institute of Research in Reproductive Health, Mumbai; National Institute of Pharmaceutical Education and Research (NIPER), etc are actively involved in basic, pre-clinical as well as clinical research to facilitate development of microbicides. Microbicide Praneem- prepared from the neem (Azadirachta indica), Sapindus mukorossi, and citrate oil has been developed. Talwar.50 Praneem has shown wide-spectrum antimicrobial activity against reproductive tract infections, including anti-retroviral properties50 and has undergone Phase-I and -II safety and acceptability studies51, 52, 53 with the help of National AIDS Research Institute (NARI), Pune. Along with polyherbal cream Basant has been proposed which has curcumin, Emblica officinalis (Amla) and Sapindus mukorossi purified extract (Aloe vera and rose water used as preservatives). Basant inhibits the growth of WHO strains and clinical isolates of Neisseria gonorrhoeae, Candida glabrata, Candida albicans, Candida tropicalis and Chlamydia and displayed a high virucidal action against HIV.54

Conclusion

Microbicide research is undergoing a period of rapid evolution. Development of safe and effective microbicides in developing countries promises to be one of the great public health concerns. Once developed these microbicides will be one of the crucial elements in any comprehensive response to HIV. Critical step will be to develop products that do not have to be used in a coastally dependent fashion. Microbicides will not only be integral to improving women’s health but also will help reduce the burden of death and disease in women and eradicate poverty in the developing world.

Source of Funding & Conflict of Interest

None.

References

1 

UNAIDS, WHO. AIDS epidemic update 2021. UNAIDS/World Health OrganizationGeneva, Switzerlandhttps://www.unaids.org/en/resources/fact-sheet

2 

National AIDS Control Organisation & ICMR-National Institute of Medical Statistics (2022). India HIV Estimates 2021: Technical Report. New Delhi: NACO, Ministry of Health & Family Welfare, Government of India2022https://naco.gov.in/sites/default/files/India%20HIV%20Estimates.pdf

3 

Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations2022144https://www.who.int/publications/i/item/9789240052390

4 

G DeBruyn NA Martinson GE Gray Male circumcision for HIV prevention: developments from sub-Saharan AfricaExpert Rev Anti Infect Ther2010812331

5 

RM Grant JR Lama PL Anderson V Mcmahan AY Liu L Vargas Preexposure chemoprophylaxis for HIV prevention in men who have sex with menN Engl J Med201036327258799

6 

SSA Karim BA Richardson G Ramjee IF Hoffman ZM Chirenje T Taha HIV Prevention Trials Network (HPTN) 035 Study Team. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention ofAIDS201125795766

7 

L Shen W Zhang Y Yuan W Zhu A Sheng Vaginal Microecological characteristics of women in different physiological and pathological periodFront Cell Infect Microbiol202212959793

8 

KN Yadav PV Kadam JA Patel MJ Patil Strychnos potatorum: phytochemical and pharmacological reviewPharmacogn Rev2018815616

9 

T Ramanathan M Premanathan K Kathiresan H Nakashima N Yamamole South East Asian Seminar on Herbs and Herbal Medicines Studies on some coastal plants for anti-HIV activity1999165Patna

10 

Y Yuan Y Cui Y Zhang HP Zhu YS Guo B Zhong Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulideInt J Pharm20124301-21149

11 

KK Singh S Parmar P Tatke Contraceptive efficacy and safety of HerbOshield™ vaginal gel in ratsContraception20128511227

12 

A Palshetkar N Pathare N Jadhav M Pawar A Wadhwani S Kulkarni In Vitro anti-HIV Activity of Some Indian Medicinal Plant ExtractsBMC Complement Med Ther20202069

13 

J Jena V Tripathi A Kumar B Kumar P Singh Rosa centifolia: Plant reviewInt J Res Pharm Chem2012237946

14 

RS Gupta JBS Kachhawa R Chaudhary Antifertility effects of methanolic pod extract of Albizia lebbeck (L.) Benth in male ratsAsian J Androl200461559

15 

P Panthong K Bunluepuech N Boonnak P Chaniad S Pianwanit Anti-HIV-1 Integrase Activity and Molecular Docking of Compounds from Albizia Procera BarkPharm Biol2015531218616

16 

H Mukherjee D Ojha P Bag H Chandel HS Bhattacharyya Anti-herpes Virus Activities of Achyranthes aspera: an Indian Ethnomedicine, and its Triterpene AcidMicrobiol Res2021168423844

17 

M Kumar S Chagan M Tomar U Prajapati V Saurabh M Hasan Custard Apple (Annona squamosa L.) Leaves: Nutritional Composition, Phytochemical Profile, and Health-Promoting Biological ActivitiesBiomolecules20211156148

18 

LM Anaya-Esparza GMM DeLourdes DJ Abraham EM Yahia NJ Salazar-López GA González-Aguilar Annonas: Underutilized species as a potential source of bioactive compoundsFood Res Int2020138Part A109775

19 

YC Wu YC Hung FR Chang M Cosentino HK Wang KH Lee Identification of ent-16β,17-dihydroxykauran-19-oic acid as an anti- HIV principle and isolation of the new diterpenoids annosquamosins A and B from Annona squamosaJ Nat Prod19965966357

20 

PV Ingole PC Mhaske SR Katade Phytochemistry and pharmacological aspects of Tridax procumbens (L.): A systematic and comprehensive reviewPhytomedicine Plus202221100199

21 

K Pathak K Zaman An Overview on Medicinally Important Plant - Annona reticulata LinnInternational Journal of Pharmacognosy and Phytochemical Research201354299301

22 

S Chavan PB Shamkuwar MG Damale D Pawar A comprehensive review on Annona reticulataInt J Pharma Sci Res2014514550

23 

I Mendoza In vitro antiviral activity and phytochemical screen in the extracts of peel from four species of tropical fruits collected in Merida YucatanMexico. Phyton2018876871

24 

D Singh B Singh R Goel Traditional uses, phytochemistry and pharmacology of Ficus religiosa: a reviewJ Ethnopharmacol2011134356583

25 

CP Trivedi S Shinde RC Sharma Preliminary phytochemical and pharmacological studies on Ficus racemosa extract (Gular)Indian J Med Res196957610704

26 

KK Baruah A Gohain Chemical composition and nutritive value of Dimaru (Ficus glomerata Roxb.) leavesIndian J Ani Nutr199291078

27 

SA Deraniyagala RLC Wijesundera O Weerasena Antifungal activity of Ficus racemosa leaf extract and isolation of the active compoundJ Nat Sci Council Sri Lanka19982611926

28 

V Halpern F Ogunsola O Obunge CH Wang N Onyejepu O Oduyebo Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in NigeriaPLoS One2008311e3784

29 

C Lee Carrageenans as Broad-Spectrum microbicides:current status and challengesMar Drugs2020189435

30 

GC Morris CJ Lacey Microbicides and HIV prevention: lessons from the past, looking to the futureCurr Opin Infect Dis2010235763

31 

G Ramjee NS Morar S Braunstein B Friedland H Jones JV DeWijgert Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South AfricaAIDS Res Ther2007420

32 

SSA Karim Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trialsFuture Microbiol2010545279

33 

SSA Karim BA Richardson G Ramjee IF Hoffman ZM Chirenje T Taha Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention ofAIDS201125795766

34 

Q Hu I Frank V Williams JJ Santos P Watts GE Griffin Blockade of attachment and fusion receptors inhibit HIV-1 infection of human cervical tissueJ Exp Med20041198106575

35 

AE Schindler Non-contraceptive benefits of oral hormonal contraceptiveInt J Endocrinol Metab2013111417

36 

D Zerodie S Holschneider Expanding on preventive options: the role of the international community in providing an enabling environment for microbicidesAIDS (London, England)20011556

37 

BS Adeleke O Babalola Pharmacological Potential of Fungal Endophytes Associated with Medicinal Plants: A ReviewJ Fungi (Basel)202172147

38 

C Chinsembu Chemical diversity and activity profiles of HIV-1 reverse transcriptase inhibitors from plantsRev Brasde Farmacognosia201929450428

39 

AJ Vlietinck T De Bruyne S Apers LA Pieters Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infectionPlanta Med199864297109

40 

IT Matsuse YA Lim M Hattori M Correa MP Gupta A search for anti-viral properties in Panamanian medicinal plants: The effects on HIV and its essential enzymesJ Ethnopharmacol19996411522

41 

T Otake H Mori M Morimoto N Ueba S Sutardjo IT Kusumoto Screening of Indonesian plant extracts for anti-human immunodeficiency virus—type 1 (HIV-1) activity19959610

42 

S El-Mekkawy MR Meselhy IT Kusumoto S Kadota M Hattori T Namba Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptaseChem Pharm Bull (Tokyo)19954346418

43 

IT Kusumoto T Nakabayashi H Kida H Miyashiro M Hattori Screening of various plant extracts used in ayurvedic medicine for inhibitory effects on human immunodeficiency virus type 1 (HIV-1) proteasePhytother Res1995931804

44 

Y Chu H Liu Advances of research on anti-HIV agents from traditional Chinese herbsAdv Dent Res20112316775

45 

A R Neurath N Strick S Jiang Y Y Li A Debnath Anti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundlesBMC Infect Dis2003266

46 

L Lopalco CCR5: From Natural Resistance to a New Anti-HIV StrategyViruses201022574600

47 

RN Fichorova Impact of T. Vaginalis Infection on Innate Immune Responses and Reproductive OutcomeJ Reprod Immunol2009831-21859

48 

QA Karim AB Kharsany JA Frohlich C Baxter N Yende LE Mansoor Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trialTrials2011126710.1186/1745-6215-12-67

49 

P Fletcher Y Kiselyeva G Wallace J Romano The Nonnucleoside Reverse Transcriptase Inhibitor UC-781 Inhibits Human Immunodeficiency Virus Type 1 Infection of Human Cervical Tissue and Dissemination by Migratory CellsJ Virol200579171117986

50 

GP Talwar P Raghuvanshi R Mishra U Banerjee A Rattan KJ Whaley Polyherbal formulations with wide spectrum antimicrobial activity against reproductive tract infections and sexually transmitted pathogensAm J Reprod Immunol200043314451

51 

SN Joshi U Katti S Godbole K Bharucha KB Kumar S Kulkarni Phase I safety study of Praneem polyherbal vaginal tablet use among HIV-uninfected women in Pune, IndiaTrans R Soc Trop Med Hyg2005991076974

52 

NS Joglekar SN Joshi SN Navlakha UR Katti SM Mehendale Acceptability of Praneem polyherbal vaginal tablet among HIV uninfected women & their male partners in Pune, India - Phase I studyIndian J Med Res2006123454752

53 

SN Joshi S Dutta BK Kumar U Katti S Kulkarni A Risbud Expanded safety study of Praneem polyherbal vaginal tablet among HIV-uninfected women in Pune, India: a phase II clinical trial reportSex Transm Infect20088453437

54 

GP Talwar SA Dar MK Rai KVR Reddy D Mitra SV Kulkarni A novel polyherbal microbicide with inhibitory effect on bacterial, fungal and viral genital pathogensInt J Antimicrob Agents20083221805



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 06-04-2023

Accepted : 18-04-2023


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijmr.2023.002


Article Metrics






Article Access statistics

Viewed: 770

PDF Downloaded: 236